SAN DIEGO, Sept. 25, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced Todd Morrow as the new President of the Company’s subsidiary HempMeds®.
In his new role, Morrow will oversee all facets of the HempMeds® organization, focusing on continued growth and development of the company’s premier brand, Real Scientific Hemp Oil. Morrow, who has more than 19 years of experience in product development, merchandising and marketing, plans to launch new product offerings and help build and maintain product registrations globally for the company.
“We are excited to have Todd as our new President to provide insightful creative and strategic direction,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Morrow is an accomplished, strategic leader and we think that HempMeds® will definitely benefit from this type of guidance.”
Prior to his new role, Morrow served as Vice President of Merchandising and Merchandise Planning & Allocation for Santa Monica-based company, Independent Pet Partners Holdings, LLC. Prior to Independent Pet Partners Holdings, LLC. Todd held various leadership positions at Petco Animal Supplies and Pirch a luxury appliance and plumbing retailer.
“I’m absolutely thrilled about this new leadership opportunity within the Medical Marijuana, Inc. portfolio of companies,” said HempMeds® President Todd Morrow. “HempMeds is a company with a rich background as a pioneer in the hemp CBD industry, and has helped people all over the world with its innovative product lines. I’m excited to play a role in strengthening the HempMeds presence worldwide.”
HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.